Analysis of risk signals for Viloxazine in the treatment of attention deficit hyperactivity disorder based on the FAERS database
Viloxazine has shown efficacy and tolerability but poses potential safety risks, particularly regarding mood, behavior, and sensory processing. Ongoing monitoring and further studies are needed.
Authors
- Rongrong Lu (ORCID: https://orcid.org/0000-0001-8671-9144)
- Ying Jiang (ORCID: https://orcid.org/0000-0003-0871-1360)
- Shuai Wang (ORCID: https://orcid.org/0000-0002-1678-0211)
- Zhiqiang Du (ORCID: https://orcid.org/0000-0002-6758-3023)
- Haohao Zhu (ORCID: https://orcid.org/0000-0003-2352-4854)
- Lin Tian
- Xuezheng Gao
Institutions
- Jiangnan University (CN)
- Wuxi Fourth People's Hospital (CN)
- Jiangxi Mental Health Center (CN)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1016/j.jad.2025.04.087
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39